Introduction
The incidence of THA is increasing 1 . Although THA is considered to be a safe and successful procedure still about 5e10% of patients are revised or sustain complications within the first 10 years after primary THA 2 .
A number of patient, implant and surgery related factors have previously been identified as risk factors for revision surgery following primary THA 3e11 . During the last decade health care provider related factors such as annual surgeon and hospital THA volume have been increasingly in focus leaving the impression that larger hospital volumes decrease the risk of various adverse events 12e22 . In a recent register-based study Singh et al. demonstrated positive relationship between larger hospital procedure volume and lower rate of 1-year mortality for both hip and knee arthroplasty 21 . A similar association between hospital THA volume and 90 days mortality after THA has been shown by Soohoo et al. 22 The occurrence of other short-term adverse events after THA such as readmission, dislocations, thromboembolic events, infections and even short-term risk of revision have been shown to be associated with procedure volume 17, 19, 21, 22 . Only a few studies examined the association between hospital procedure volume and long term risk of revision, and none of them found such an association 14, 18, 20, 23 .
Even though these four studies are large, population-based and with follow-up times between 1 and 12 years, different geographical settings and healthcare systems impede the generalizability of their results. The aim of our study was to investigate the association between hospital procedure volume and risk of implant revision surgery after primary THA in patients suffering from osteoarthritis (OA) in the Nordic countries from 1995 to 2011 using the Nordic Arthroplasty Register Association database (NARA). The investigation included revision due to all causes, specific causes and in relation to fixation type.
Patients and methods

Data sources
The NARA database was established in 2007. It holds merged individual-based data concerning diagnosis, primary surgery, type of implant and revision from the Danish, Finnish, Norwegian and Swedish hip and knee arthroplasty registers 24, 25 . On a regular basis all uniform variables from each national register are re-coded according to common definitions and anonymized and then merged into the NARA database. The linkage between primary procedure and subsequent revision or death on individual data is performed in each national register before merged into the NARA database. Each of the four national registers holds data from both public and private hospitals.
Study population
All primary THAs due to primary OA between 1st January 1995 and 31st of December 2011 were included. Hip resurfacing arthroplasties were excluded while other metal on metal THAs were included. Bilateral THAs were included. No age restriction was made. THAs with missing information on primary hospital were excluded (n ¼ 5). In total 417,687 primary THAs were included in this study. The characteristics of the study population according to hospital volume groups are presented in Table I .
Exposure e hospital volume
Each procedure was entered into one of five hospital THA volume groups according to the number of primary THAs due to primary OA at the hospital in the year of the procedure. The volume groups were 1e50, 51e100, 101e200, 201e300 and >300 primary THAs per year. Hospitals with fluctuating procedure volume contributed to more than one volume group. Thus, a hospital performing 188 procedures in 2010 and 204 in 2011 contribute to volume group 101e200 in 2010 and to volume group 201e300 in 2011.
Outcome e revision
The primary outcome of interest was first time implant revision from all causes. Revision was defined as any new surgical procedure including both partial and complete change and/or removal of a primary implant. Each primary THA was linked to the following first time revision, if present, using the patients civil personal registration number. Follow-up started on the day of primary surgery and ended on day of revision, patient death with the implant in situ or December 31st, 2011 whichever came first.
Statistical analysis
The descriptive statistics included median age at primary THA, sex and type of fixation. For the primary outcome of interest cumulative incidence estimation in the presence of death as a competing risk was calculated and visualized graphically. The Pseudo Value Approach 26e28 taking death as a competing risk into account was used to assess the relative risk (RR) of revision from all causes 1, 2, 5, 10 and 15 years after primary surgery. We adjusted for the following confounding factors; age at primary procedure (in categories 10e49, 50e59, 60e69, 70e79 and 80þ years) and sex. Type of fixation was e using both the Wald Test and the Likelihood Ratio Test at 10 years follow up on revision from all causes e tested to be an effect modifier (for both tests P < 0.00). Therefore, analyses were made on cemented THA and uncemented THA separately. Hybrids were, to keep it simple, omitted when looking at association between hospital volume and risk of revision in relation to type of fixation. Sensitivity analysis using the same statistical approach was made on first time implant revision from specific causes (aseptic loosening, dislocation and deep infection) 2 and 10 years after primary surgery. In all analyses, the group with the lowest primary THA volume (annual volume of 1e50 THAs) acted as the reference group. Due to both the age of the patient at primary surgery and the long expected survival of the implant death is to be considered as a competing risk to revision 29, 30 . By doing so we avoid overestimating the risk of revision as would be the case with standard survival analysis. A possible correlation among patients treated in the same hospital (case mix related to hospitals) is dealt with by correcting for clustering using robust estimates of the variance. Risk estimates were presented with 95% CI and P-values relative to volume group 1e50. For the sensitivity analyses only adjusted RR was presented. P-values <0.05 were taken to donate statistical significance. The analyses were performed using the Stata Statistical Software; Release 12.0, StataCorp LP.
Ethics
Permission to the study was obtained from the Danish Data Protection Agency (reference number: 2012-41-06636). As both individuals and hospitals were anonymized before entering the NARA database, it was not possible to identify both on an individual basis in the NARA database.
Results
The annual number of THAs increased almost two-fold from 16,501 in 1995 to 31,328 in 2011 (Fig. 1) . During the period from 1995 to 2011 the annual number of primary THAs increased in the three largest volume groups e most pronouncedly in the largest annual hospital volume group (volume of >300 THAs), whereas the annual number of primary THAs in the two smallest hospital volume groups decreased. Number of THAs at risk for revision was largest in hospital volume group 50e100 and hospital volume group 101e200 at all time points (Table I) . Number of THAs at risk in the two largest hospital volume group (volumes of 200e300 and >300 THAs) were limited 10 and 15 years after primary procedure (Table I ). The number of hospitals performing 100 or less primary THAs per year decreased from 1995 to 2011. At the same time the number of hospitals operating more than 101 primary THAs per year increased (Table I) .
The median follow-up time was 5.7 years ranging from 0 to 17 years (Table I ). The longest median follow-up time at 7.5 years was seen for hospital volume group 1e50. The follow-up time decreased gradually with increase in hospital volume group resulting in a follow-up time of median 3.0 years in volume group >300.
Revision from any cause
In total, 19.734 (4.7%) first time implant revisions were performed over the study period. The overall cumulative incidence of revision was 1.4% (CI 1.3e1.5) 1 year after primary THA. At 2 years, it had increased to 1.8% (CI 1.7e1.9), at 5 years to 2.9% (CI 2.8e3.0), at 10 years to 5.9% (CI 5.7e6.1) and at 15 years the overall cumulative incidence of revision was 9.2% (CI 8.9e9.4). Cumulative incidences for each volume group can be seen in Fig. 2 .
Revision from all causes e cemented THA There were in total 263,176 (63%) cemented THAs (Table III) . No differences were found in the adjusted RR between any of the 71 (13) 70 (13) 70 (13) 70 (13) 69 (14) 70 ( hospital volume groups 1 year after primary THA (Table II) . At 2, 5 and 10 years all hospital volume groups had a reduced RR compared to the reference group (annual volume of 1e50 THAs) (Table II) . At 15 years all but hospital volume group 201e300 had a reduced RR compared to the reference group. The specific periods in which volume is most important were 2e5 years and 5e10 years after primary procedure. Here the reduction of adjusted RR of revision varied between 21% and 43% in the four largest volume groups compared to the reference group. For hospital volume group >300 the magnitude of RR reduction grew with increased follow up (Table II) .
Revision from all causes e uncemented THA There were 97,534 (23%) uncemented THAs. At 1 and 2 years, no differences in RR were seen (Table III) . At 5, 10 and 15 years, solely hospitals producing between 201 and 300 procedures per year had a reduced RR of revision compared to the reference group. For hospital volume group 50e100, 101e300 and >300 no differences were found in the adjusted RR compared to the reference group (Table III) .
Revision due to specific causes
The main reason for implant revision was aseptic loosening. It accounted for 49% of all the revisions, 56% in the cemented THAs and 32% in the uncemented THAs. For both the cemented THAs and uncemented THAs the share of revisions due to aseptic loosening decreased with increasing hospital volume. For the cemented THAs all the four largest hospital volume groups had a reduced RR compared to the reference group (annual volume of 1e50 THAs) both 2 and 10 years after primary THA. For the uncemented THAs no differences were found in the adjusted RR compared to the reference group neither 2 nor 10 years after primary THA (see Table IV ).
Dislocation accounted for 20% of all the revisions. There were no differences in RR between the reference group and the larger hospital volume groups after 2 years follow up. After 10 years follow up hospital volume group 101e200 had a reduced risk of revision compared to the reference group (Table V) . Deep infections accounted for 13% of the revisions. There were no differences in RR due to deep infection between the reference group and the larger volume groups neither 2 nor 10 years after primary THA (Table V) . Due to low numbers of primary THAs and even smaller numbers of revisions in the compared hospital volume groups we were not able to estimate risk of revision due to dislocation and infection for the cemented THAs and the uncemented THAs. 
Discussion
For cemented THA we found a consistent association between annual hospital THA volume and long term risk of implant revision. To be more specific, a mean annual hospital THA volume of 50 THAs or less per year increased the risk of revision after 2, 5, 10 and 15 years after primary cemented THA in patients operated on for primary OA. To the best of our knowledge, this is the largest study to evaluate presence of any association between hospital procedure volume and risk of revision.
We acknowledge some limitations in our study. First, registration of primary THA and revisions in the national hip registers is not 100%, but close 31e33 . Although we may miss some revisions due to prospective registration of data, we have no reason to believe that missing revisions are related to certain hospital volume groups. Second, we used hospital procedure volume as the exposure. A relevant alternative would be surgeon procedure volume. Ravi et al. showed recently that adverse events after THA were increased in patients treated by surgeons performing less than 35 procedures per year 34 . Additionally Katz et al. showed that the risk of revision after THA was increased for low volume surgeons in the first 18 month after primary THA 23 . We do not have information about surgeon procedure volume in the NARA database and since it is not possible to extrapolate our hospital volume to surgeon volume residual confounding may influence our estimations. Finally, the main outcome in our study was revision surgery. In order to improve our understanding of the long-term clinical course of patients undergoing THA surgery it would be preferable to also examine other clinical adverse events and patient reported outcomes following THA. Unfortunately, these data were not available in the NARA database. Another issue that might play a role in the interpretation of our results is the fact that small volume hospitals represent a larger share of the total amount of THAs in the early study period compared to the more recent study period where large volume hospitals are over-represented. So, provided that older implants are of poor quality and newer implants are of better quality, one can argue that our findings of a positive long term association between hospital volume and risk of revision are more related to implant quality than to hospital volume. However, this premise of old/new implants being of more inferior/superior quality can be questioned. Additionally, data from the national registers from Sweden and Denmark which constitute parts of the NARA database do not unambiguous support a premise like this 31, 33 . We had a priory chosen five hospital volume groups with fixed cut points. Our hospital volume groups correspond very much to those used by Judge et al. 14 The smaller hospital volume groups were identical while the large volume groups in their study used larger cut point therefore reflecting demographic differences between England and the Nordic countries. As different grouping might give rise to different results we casted a sidelong glance to other studies in the preparation of the present study. However, the variety in hospital volume groups is large and impedes a direct comparison between studies. On the other hand, a consensus seems difficult because of differences in national heterogeneities and study designs. Four different register studies using similar methods compared to us did not find any association between hospital procedure volume and short or long term risk of revision after THA 14, 18, 20, 23 . In the largest of these studies, the study by Judge et al. based on 281.000 patients from England, the authors found no evidence that volume was associated with risk of revision within 5 years of primary surgery 14 . The same result was found in 31,000 patients from Canada 1 year after primary surgery 20 . In more than 25,000
Medicare patients in USA Manley et al. found no association between hospital procedure volume and revision 6 month, 2, 5 and 8 years after primary procedure 18 . Same result was found by Katz et al. in a more recent and larger study based on Medicare patients in USA 23 . Here the authors didn't find justification for hospital procedure volume being a risk factor for revision after THA with 12 years of follow up 23 . Methodological differences, differences in populations and healthcare systems between our study and the referred studies might give rise to these conflicting findings. 18, 20, 23 Associations between hospital procedure volume and risk of revision were adjusted for age and sex. In the referred studies adjustments also included co-morbidity, hospital teaching status and surgeon volume 18, 20 . These data were not available in the NARA database. Consequently, residual confounding affecting an association in our study may be present. Hospital volume was associated with the risk of revision in the cemented THA group. Already at 2 years the larger hospital volume groups were superior compared to the group with the lowest .
A new study population and the fact that much has happened in the treatment of THA since the study by Espehaug et al. might explain our slightly diverging findings in relation to the cemented THAs.
When analyzing risk of revision due to specific causes we found, that hospital THA volume clearly matters when it comes to risk of revision due to aseptic loosening. For the cemented THAs the largest hospital volume groups again had reduced RR compared to the group with the lowest annual THA volume. These significant findings and the fact that the risk estimates decreased with increase in hospital volume indicate that high volume hospitals might be less affected by learning curve issues. Even though high volume hospitals are mainly teaching hospitals, with a high share of residents these hospitals manage to reduce risk of revision due to aseptic loosening in cemented THA. This implies that not only surgical skills but also other routines and professions skills play a part in the outcome after THA. Even though the superior findings in relation to aseptic loosening relate solely to cemented THA it seems evident in economic terms to encourage the use of large THA volume hospitals. These hospitals are both on short and long term, able to reduce the number of revisions due to the far most frequent cause, aseptic loosening in cemented THA.
In the Nordic countries, like in many other countries, the annual number of THAs has steadily increased. Additionally, the amount of hospitals operating 50 THAs per year or less has decreased reflecting the general centralization that has taken place in the Nordic healthcare systems. This development seems expedient due to the observed reduced risk of revisions after primary THA in high volume hospitals.
Conclusion
This study showed a consistent and strong association between hospital procedure volume and long-term risk of revision after primary THA e primarily based on an association in the large group of cemented THAs. Hospitals operating less than 50 procedures per year had an increased risk of revision due to all causes 2, 5, 10 and 15 years after primary cemented THA. There may also be an association between hospital volume and risk of revision in uncemented THAs, however based on this study the association seems less pronounced.
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